Soligenix Inc. (SNGX)

1.72
0.04 2.22
NASDAQ : Health Technology
Prev Close 1.76
Open 1.80
Day Low/High 1.70 / 1.80
52 Wk Low/High 1.60 / 4.05
Volume 12.24K
Avg Volume 149.80K
Exchange NASDAQ
Shares Outstanding 8.74M
Market Cap 15.30M
EPS -1.20
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Soligenix - Driving Towards Key Inflection Points With Two Pivotal Phase 3 Clinical Trials

Soligenix - Driving Towards Key Inflection Points With Two Pivotal Phase 3 Clinical Trials

Company provides 2017 highlights and 2018 development program guidance

Soligenix Announces US Patent Issuance For Use Of Dusquetide In Oral Mucositis

Soligenix Announces US Patent Issuance For Use Of Dusquetide In Oral Mucositis

Specific therapeutic use claim in oral mucositis adds to existing composition of matter claims

Soligenix Announces Recent Accomplishments And Third Quarter 2017 Financial Results

Soligenix Announces Recent Accomplishments And Third Quarter 2017 Financial Results

2017 Non-Dilutive Funding Exceeds $8M

EMC Buys $6.4M More of VMware

EMC Corp buys another 90,000 shares.

CEO Sells $6.1M Worth of Liberty Media

Jonathan Moreland, author of InsiderInsights, gives you the lowdown on top stock purchases and sales.

TheStreet Quant Rating: D (Sell)